age recommendation for shingles shot
The shingles vaccine (Zostavax) is recommended for adults age 60 and older, whether they've already had shingles or not. Although the vaccine is approved for people age 50 and older, the Centers for Disease Control and Prevention isn't recommending it until you reach age 60. The decision on when to get vaccinated should be made with your healthcare provider. Shingles vaccine is approved by the Food and Drug Administration for people aged 50 years and older. However, CDC does not have a recommendation for routine use of shingles vaccine in people 50 through 59 years old. March 24, 2011 - People age 50 and older can now get Merck's Zostavax shingles vaccine, the FDA today ruled. The vaccine already was approved for people age 60 and older. The approval is based on a Merck clinical trial that showed the vaccine to be about 70% effective in preventing shingles in the younger age group. However, CDC does not have a recommendation for routine use of shingles vaccine in people aged 50 through 59 years old. Adults aged 50 through 59 years who have questions about the shingles vaccine should discuss the risks and benefits with a health care provider. CDC recommends that people 60 years old and older get shingles vaccine to prevent shingles and PHN. Shingles vaccine has been used since 2006. Zostavax® is the only shingles vaccine currently approved for use in the United States. This vaccine reduces the risk of developing shingles by 51% and PHN by 67%. Talk with your healthcare professional if you have questions about shingles vaccine. Shingles vaccine is approved by FDA for people aged 50 years and older. However, CDC does not have a recommendation for routine use of shingles vaccine in people aged 50 through 59 years old. People 60 years of age or older should get shingles vaccine. They should get the vaccine whether or not they recall having had chickenpox, which is caused by the same virus as shingles. Studies show that more than 99% of Americans aged 40 and older have had chickenpox, even if they don't remember getting the disease. FDA approves Zostavax vaccine to prevent shingles in individuals 50 to 59 years of age. The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older. March 24, 2011 - People age 50 and older can now get Merck's Zostavax shingles vaccine, the FDA today ruled. The vaccine already was approved for people age 60 and older.
60 Year